
LifeMD (LFMD) Stock Forecast & Price Target
LifeMD (LFMD) Analyst Ratings
Bulls say
LifeMD is a high-growth, direct-to-patient healthcare company that offers convenient and cost-effective virtual medical care and pharmacy services. With a strong portfolio of brands, including a nationwide pharmacy network, a wholly-owned commercial pharmacy, and a fully integrated patient care center, the company is well-positioned to capitalize on the growing demand for telehealth and digital health services. Its recent collaboration with Novo Nordisk to offer FDA-approved weight loss treatments further showcases its commitment to providing high-quality healthcare options. While the industry is competitive and subject to uncertainties such as the impact of COVID-19, the company's strong financials, with a projected EV/Revenue multiple of 2.3x, and strategic partnerships make it a promising investment opportunity.
Bears say
LifeMD is facing significant headwinds due to lower-cost competitors in the weight management sector and the transition to branded GLP-1s has created revenue lumpiness. Additionally, the company's current cash position and negative cash flow from operating activities may not be sufficient for future operations, and there are various risks associated with being a young, high-growth company in the healthtech space. These factors lead to a negative outlook on LifeMD's stock.
This aggregate rating is based on analysts' research of LifeMD and is not a guaranteed prediction by Public.com or investment advice.
LifeMD (LFMD) Analyst Forecast & Price Prediction
Start investing in LifeMD (LFMD)
Order type
Buy in
Order amount
Est. shares
0 shares